EUVIMEDEUVIMED entdecken
Crossref

Targeted Delivery of Thymoquinone‐Encapsulated Polyethyleneimine/Poly (Lactic Acid) Nanoparticles Into Breast Cancer Cells

Jeganpandi Senthamarai Pandi, Parasuraman Pavadai iD, Ewa Babkiewicz, Theivendren Panneerselvam, Piotr Maszczyk iD, Murugesan Sankaranarayanan iD, Mohankumar Ramar, Selvaraj Kunjiappan

Drug Development Research · 2026

DOI: 10.1002/ddr.70217 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Development Research, 2026. Verfasst von Jeganpandi Senthamarai Pandi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, Kalasalingam Academy of Research and Education, Krishnankoil, Tamil Nadu, India. Hauptthemen laut MEDLINE: Benzoquinones, Polyesters, Polyethyleneimine, Nanoparticles. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 68 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast cancer is the most commonly diagnosed cancer globally, predominantly affecting older women. Thymoquinone (TQ) is a natural therapeutic agent that exerts anticancer efficacy. However, its pharmacological effects are restricted by inadequate aqueous solubility and bioavailability. The present study aimed to develop TQ‐encapsulated polyethyleneimine/poly(lactic acid) nanoparticles (TQ‐PEI/PLA‐NPs) to enhance the delivery of TQ into breast cancer cells. The solvent evaporation‐emulsification method was employed to synthesize TQ‐PEI/PLA‐NPs, and their physicochemical properties were subsequently examined. TQ‐PEI/PLA‐NPs had a crystalline structure, a zeta potential of +1 mV, and a spherical shape with a diameter of 80–90 nm. The encapsulation efficiency was 85.77 ± 2.21% (w/w), while the drug loading capacity was 9.32 ± 1.14% (w/w). The release rate of TQ from TQ‐PEI/PLA‐NPs was marginally elevated at pH: 5.8 (81.21 ± 0.87%) compared to pH 3.5 and 7.2. MTT assay using TQ‐PEI/PLA‐NPs confirmed concentration‐dependent cytotoxicity against MCF‐7 cells after 24 h of treatment, and IC 50 was found to be 21.99 μg/mL. The intracellular delivery of TQ in MCF‐7 cells caused cell death, as indicated by AO/EBr staining, mitochondrial transmembrane potential assay, and Caspase‐3 and ‐9 investigations. The observed MCF‐7 cell death attributed to TQ was induced by reactive oxygen species (ROS) and impaired mitochondrial membrane potential. The ROS potentially damaged the mitochondrial membrane, and further studies supported the induction of apoptosis. Our results indicated that TQ‐PEI/PLA‐NPs, which cause cytotoxicity to breast cancer cells, as evidenced by the decreased MCF‐7 cell counts, may exhibit significant therapeutic potential for breast cancer therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BenzoquinonesPolyestersPolyethyleneimineNanoparticlesBreast NeoplasmsAntineoplastic AgentsHumansFemaleMCF-7 CellsApoptosisReactive Oxygen SpeciesDrug Delivery SystemsDrug LiberationCell SurvivalDrug Carriers

Stichwörter der Autor:innen

apoptosisbreast cancer cellsdrug releasepolymeric nanoparticlesthymoquinone

Substanzen

thymoquinoneBenzoquinonesPolyesterspoly(lactide)PolyethyleneimineReactive Oxygen SpeciesAntineoplastic AgentsDrug Carriers

Autor:innen und Institutionen

  • Department of Biotechnology, Kalasalingam Academy of Research and Education, Krishnankoil, Tamil Nadu, India.
  • Department of Pharmaceutical Chemistry, Faculty of Pharmacy, M.S. Ramaiah University of Applied Sciences, Bengaluru, India.
  • Department of Hydrobiology, Institute of Ecology, Faculty of Biology, University of Warsaw, Warsaw, Poland.
  • Biological and Chemical Research Centre, University of Warsaw, Warsaw, Poland.
  • Department of Pharmaceutical Chemistry and Analysis, Vels Institute of Science, Technology, and Advanced Studies, School of Pharmaceutical Sciences, Chennai, Tamil Nadu, India.
  • Medicinal Chemistry Research Laboratory, Department of Pharmacy, Birla Institute of Technology and Science Pilani, Pilani, Rajasthan, India.

ORCID-Profile: Parasuraman Pavadai, Piotr Maszczyk, Murugesan Sankaranarayanan

Zitieren

APA

Pandi, J. S., Pavadai, P., Babkiewicz, E., Panneerselvam, T., Maszczyk, P., Sankaranarayanan, M., Ramar, M., & Kunjiappan, S. (2026). Targeted Delivery of Thymoquinone‐Encapsulated Polyethyleneimine/Poly (Lactic Acid) Nanoparticles Into Breast Cancer Cells. Drug Development Research. https://doi.org/10.1002/ddr.70217

Vancouver

Pandi JS, Pavadai P, Babkiewicz E, Panneerselvam T, Maszczyk P, Sankaranarayanan M, et al. Targeted Delivery of Thymoquinone‐Encapsulated Polyethyleneimine/Poly (Lactic Acid) Nanoparticles Into Breast Cancer Cells. Drug Development Research. 2026. doi:10.1002/ddr.70217

BibTeX
@article{Pandi2026,
  author = {Pandi, Jeganpandi Senthamarai and Pavadai, Parasuraman and Babkiewicz, Ewa and Panneerselvam, Theivendren and Maszczyk, Piotr and Sankaranarayanan, Murugesan and Ramar, Mohankumar and Kunjiappan, Selvaraj},
  title = {Targeted Delivery of Thymoquinone‐Encapsulated Polyethyleneimine/Poly (Lactic Acid) Nanoparticles Into Breast Cancer Cells},
  journal = {Drug Development Research},
  year = {2026},
  doi = {10.1002/ddr.70217}
}
Kostenlos starten →